REQUEST A DEMO
Total
USD $0.00
Search more companies

Gpc Pharma S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Gpc Pharma S.A.S. Profile Updated: June 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Gpc Pharma S.A.S. is a company in Colombia, with a head office in Medellin. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on November 12, 2015. Gpc Pharma S.A.S. currently employs 30 (2024) people. There was a net sales revenue drop of 2.98% reported in Gpc Pharma S.A.S.’s latest financial highlights for 2023. During that time, Gpc Pharma S.A.S.’s total assets decreased by 17.56%. The net profit margin of Gpc Pharma S.A.S. increased by 3.94% in 2023.

Headquarters
Carrera 45 7 75
Medellin; Antioquia;

Contact Details: Purchase the Gpc Pharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Gpc Pharma S.A.S. report to view the information.
Outstanding Shares:
Purchase the Gpc Pharma S.A.S. report to view the information.
Incorporation Date:
November 12, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Gpc Pharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-2.98%
Total operating revenue
-12.54%
Operating profit (EBIT)
27.22%
EBITDA
25.67%
Net Profit (Loss) for the Period
37.59%
Total assets
-17.56%
Total equity
56.84%
Operating Profit Margin (ROS)
5.39%
Net Profit Margin
3.94%
Return on Equity (ROE)
-5.07%
Debt to Equity Ratio
-206.83%
Quick Ratio
-0.35%
Cash Ratio
-0.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?